The endocrine system consisting of several glands such as pineal, pituitary, and thyroid and secretory organs such as hypothalamus and pancreas, releases hormones directly into the blood stream and regulate the body functioning. Some hormones (cortisol, follicle-stimulating hormone, luteinizing hormone) have a daily or monthly pattern of release. Other hormones are generally present in very small quantities in the blood and are released in specific situations, such as the release of epinephrine (adrenaline) from the adrenal glands in response to stress. The goals of endocrine testing are to identify the hormone(s) that are being over or under-produced, to determine which gland(s) are involved, and to determine the cause of the hormone imbalance. This may involve measuring hormone levels and their metabolites in the blood and/or urine. Stimulation or suppression testing may be utilized to evaluate hormone production and/or gland interaction with other glands and hormones. The endocrine laboratory tests help in detecting the deviations in the secretion of the hormones to understand the disorders like infertility, menopause, thyroid dysfunction. The major driving factors of endocrine disorders testing market includes increasing health care awareness rise of endocrine disorders such as diabetes, thyroid disorders, and infertility, and advancement of the technology.
The global endocrine disorders testing market segmentation is based on test type (cortisol test, dehydroepiandrosterone sulfate test, estradiol test, follicle stimulating hormone test, human chorionic gonadotropin test, insulin test, luteinizing hormone test, progesterone test, prolactin test, testosterone test, thyroid stimulating hormone test, others – gastrin, thymosin, secretin), technology (tandem mass spectrometry, immunoassay technologies, monoclonal and polyclonal antibody technologies, sensor technologies, clinical chemistry technologies, other technologies), and end users (hospitals, commercial laboratories, ambulatory care centers, home-based tests, physician offices, others).
The global endocrine disorders testing market report provides market size (Revenue US$ Million 2014 to 2021), market share, trends and forecasts growth trends (CAGR%, 2017 to 2021). The global endocrine disorders testing market research report is further segmented by geography into North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), Latin America (Brazil, Mexico, Rest of LA), and Rest of the World. The global endocrine disorders testing market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market by company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market.
Major players operating in the global endocrine disorders testing market and profiled in this report include Abbott Laboratories, AB Sciex Pte. Ltd., Agilent Technologies, Biomedical Diagnostics, bioMerieux SA, Bio-Rad Laboratories, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Laboratory Corporation of America Holdings (LabCorp), Ortho-Clinical Diagnostics, Quest Diagnostics, Siemens Healthcare GmbH (Siemens AG), Sysmex Corporation., and Thermo Fisher Scientific, Inc.